Webcasts of two-day US Workshop on Long COVID (PASC) now online
Simon Collins, HIV i-Base
The increasing awareness of the complexity of post-acute symptoms related to COVID-19 was covered in a two day workshop organised by the US National Institutes of Health (NIH). 
Long COVID is also called Post-Acute Sequelae of COVID-19 (PASC), post COVID and long haul COVID.
The workshop, including breakout sessions, in now webcast with open access.
The workshop opens with an overview of the current challenges and includes talks on clinical observations (both US and international), and some insights from the patient’s perspective.
Further talks cover pathology coronaviruses as well as host immune responses.
The second day starts with a talk on social determinants of health and race/ethnicity that are expanded in focus groups.
Long COVID: Day 1
Session 1: Post-acute COVID-19: clinical observations
- Epidemiological and clinical landscape
- Experience from US clinics
- Global perspective: experience from South Africa
- The post-acute COVID-19 experience
Session 2: Viral pathogenic features and host immune response
- Immunological Responses to SARS-CoV-2 Infection and Potential Role in Post-Acute Sequelae
- (B cells/Antibodies)
- (T cells)
- (Multisystem Inflammatory Syndrome in Children)
- Pathogenic Features of Coronaviruses and Manifestations of Extrapulmonary Infection
- Approaches to Researching Post-Acute Sequelae of SARS-CoV-2 Infection
Session 3: Post-acute COVID-19 perspectives
- Neurological/psychiatric/neuromuscular, cardiovascular, pulmonary, renal/GI/metabolic, immunologic/rheumatologic, paediatric
Long COVID – DAY 2
Impact of Social Determinants of Health, Race and Ethnicity on Post-Acute COVID-19 Sequelae
Reports from breakout sessions.
This report was first posted on 5 January 2021.
An international community study on Long COVID Community study on long COVID has recently been published as a pre-review draft and will be reviewed in the next edition of HTB. 
- NIH Workshop. 3-4 December 2020.
- Davis HE et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. Pre-review draft. MedRxiv. DOI: 10.1101/2020.12.24.20248802. (27 December 2020).